Related Experiment Videos

Cytokine mRNA profiles during the course of experimental Haemophilus influenzae bacterial meningitis

A Diab1, J Zhu, L Lindquist

  • 1Division of Neurology, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.

Insights

This study shows that Haemophilus influenzae type b (Hib) meningitis in rats triggers cytokine responses in the brain, spleen, and cerebrospinal fluid (CSF). Promoting TGF-beta and IL-10 may aid in treating bacterial meningitis.

Area of Science:

  • Immunology
  • Neuroscience
  • Microbiology

Background:

  • Bacterial meningitis, particularly Haemophilus influenzae type b (Hib), poses significant health risks.
  • Understanding the host's immune response, including cytokine profiles, is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the temporal expression of cytokine mRNA in Sprague-Dawley rats following intraperitoneal inoculation with Hib.
  • To determine the localization of cytokine-expressing cells in the brain, cerebrospinal fluid (CSF), and spleen.

Main Methods:

  • Intraperitoneal inoculation of 3-week-old Sprague-Dawley rats with Hib.
  • In situ hybridization to quantify cytokine mRNA levels in brain, CSF, and spleen at various time points post-inoculation (12, 48, and 72 hours).
  • Monitoring for nonlethal meningitis, leukocyte counts in CSF, and bacterial cultures.

Main Results:

  • Elevated levels of IFN-gamma, IL-1 beta, IL-4, IL-6, IL-10, IL-12, and TNF-alpha mRNA were observed in spleen and CSF at 12 hours post-inoculation.
  • Strong expression of IL-6 and TGF-beta was detected in the brain at 12 hours, with IL-10 elevated at 48 hours.
  • Delayed cytokine induction was noted in the CSF compared to spleen and brain, with TGF-beta peaking at 48 hours and other cytokines showing elevation at 72 hours.

Conclusions:

  • The study reveals a dynamic cytokine response in rats with Hib-induced meningitis, with distinct temporal and spatial patterns.
  • The findings suggest that therapeutic strategies aimed at enhancing TGF-beta and/or IL-10 production could be beneficial for treating bacterial meningitis.

Related Concept Videos